Phase II study of weekly docetaxol combined with cisplatin and 5-FU [fluorouracil] in patients with advanced gastric cancer

Trial Profile

Phase II study of weekly docetaxol combined with cisplatin and 5-FU [fluorouracil] in patients with advanced gastric cancer

Discontinued
Phase of Trial: Phase II

Latest Information Update: 26 Apr 2011

At a glance

  • Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Fluorouracil (Primary)
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Acronyms DCF-AGC
  • Most Recent Events

    • 29 Jan 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 25 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top